Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Tioga reports reduced nighttime itching in asimadoline study in atopic dermatitis

Dec. 5, 2017

Impoyz approved in U.S. for plaque psoriasis

Dec. 4, 2017

EMA gives orphan drug designation to ProQR Therapeutics' QR-313

Nov. 30, 2017

European Commission approves Tremfya

Nov. 23, 2017

Menlo Therapeutics begins enrollment in PSORIXA study of serlopitant

Nov. 22, 2017

Bristol-Myers Squibb commences phase I/II trial of BMS-986251 for psoriasis

Nov. 20, 2017

Phase II study of topical radezolid for acne begins

Nov. 15, 2017

Devonian Health Group begins phase IIa study of Thykamine in atopic dermatitis

Nov. 13, 2017

KB-103 granted orphan drug designation by the FDA

Nov. 8, 2017

AnaptysBio reports topline phase I results for ANB-019

Nov. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...